Integra Lifesciences Holdings (IART) Return on Invested Capital (2011 - 2026)

Integra Lifesciences Holdings (IART) has 14 years of Return on Invested Capital data on file, last reported at 0.03% in Q1 2026.

• For the quarter ending Q1 2026, Return on Invested Capital fell 3.0% year-over-year to 0.03%; the trailing twelve-month figure through Mar 2026 stood at 0.03% (down 3.0% YoY), and the FY2025 full-year result was 0.01%, down 2.0% from the prior year.
• Return on Invested Capital fell to 0.03% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.01% in Q1 2022 to a low of 0.03% in Q1 2026.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2022 and slipped 3 bps in 2026, its largest moves.
• Tracing IART's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then surged by 45 bps to 0.01% in 2023, then sank by 98 bps to 0.0% in 2024, then plunged by 9854 bps to 0.01% in 2025, then sank by 160 bps to 0.03% in 2026.
• Business Quant data shows IART's Return on Invested Capital at 0.03% in Q1 2026, 0.01% in Q4 2025, and 0.0% in Q3 2025.